ArticlebioRxiv : the preprint server for biology2024
CCAFE: Estimating Case and Control Allele Frequencies from GWAS Summary Statistics.
Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
Abstract
Methods involving summary statistics in genetics can be quite powerful but can be limited in utility. For instance, many post-hoc analyses of disease studies require case and control allele frequencies (AFs), which are not always published. We present two frameworks to derive case and control AFs from GWAS summary statistics using the odds ratio, case and control sample sizes, and either the total (case and control aggregated) AF or standard error (SE). In simulations and real data, derivations of case and controls AFs using total AF is highly accurate across all settings (e.g., minor AF, condition prevalence). Conversely, derivations using SE underestimate common variant AFs (e.g. minor allele frequency >0.3) in the presence of covariates. We develop an adjustment using gnomAD AFs as a proxy for true AFs, which reduces the bias when using SE. While estimating case and control AFs using the total AF is preferred due to its high accuracy, estimating from the SE can be used more broadly since SE can be derived from p-values and beta estimates, which are commonly provided. The methods provided here expand the utility of publicly available genetic summary statistics and promote the reusability of genomic data. The R package
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.